Data Analysis Shows Significant New Onset Morbidity Post-COVID-19 in Children, Adolescents, Adults
November 21, 2022 03:23pm
By Jill Murphy, Associate Editor
Read about the new Rx products featured in April 2017.
The FDA has expanded the indicated for the approved Spiriva Respimat (tiotropium bromide) for the long-term, once-daily maintenance treatment of asthma in individuals 6 years and older.
Oral inhalation: 1.25 mcg
For more information: spiriva.com
The FDA has approved Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on hemodialysis.
Injection: 2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL
For more information: amgen.com
The FDA approved Eli Lilly’s updated label for its type 2 diabetes drug, Trulicity (dulaglutide), to include use in combination with basal insulin for adults with type 2 diabetes. The FDA included the changes to the approved product labeling to reflect this important information for prescribers.
Injection: 0.75 and 1.5 mg
For more information: trulicity.com